Cargando…

Editorial: Spotlight on resistant and refractory migraine

Detalles Bibliográficos
Autores principales:	Ornello, Raffaele, Raffaelli, Bianca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565493/ https://www.ncbi.nlm.nih.gov/pubmed/37830091 http://dx.doi.org/10.3389/fneur.2023.1291439

Ejemplares similares

Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series
por: Ornello, Raffaele, et al.
Publicado: (2022)

Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index
por: Sette, Lucia, et al.
Publicado: (2022)

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Editorial: Lifestyle modifications to manage migraine
por: Woldeamanuel, Yohannes W., et al.
Publicado: (2022)

Editorial: Biomarkers in migraine beyond diagnosis
por: Chen, Zhiye, et al.
Publicado: (2022)

Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
por: Raffaelli, Bianca, et al.
Publicado: (2020)

Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
por: Robblee, Jennifer
Publicado: (2023)

Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021)

Editorial: Neurogenic inflammation in paroxysmal disorders (migraine and epilepsy)
por: Xiao, Zheman
Publicado: (2023)

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)
por: Oliveira Gonçalves, Ana Sofia, et al.
Publicado: (2022)

A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

Editorial: Advances in diagnosing and treating new-onset refractory status epilepticus (NORSE)
por: Thomschewski, Aljoscha, et al.
Publicado: (2023)

Association between sleep quality, migraine and migraine burden
por: Duan, Shaojie, et al.
Publicado: (2022)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
por: De Matteis, Eleonora, et al.
Publicado: (2022)

Patterns of Migraine in Postmenopausal Women: A Systematic Review
por: Ornello, Raffaele, et al.
Publicado: (2021)

Comorbidities of Migraine
por: Wang, Shuu-Jiun, et al.
Publicado: (2010)

Associations between anxiety, depression with migraine, and migraine-related burdens
por: Duan, Shaojie, et al.
Publicado: (2023)

Pain Perception and Migraine
por: Russo, Antonio, et al.
Publicado: (2018)

Migraine and hemorrhagic stroke: data from general practice
por: Ornello, Raffaele, et al.
Publicado: (2015)

Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine
por: Allais, Gianni, et al.
Publicado: (2016)

Editorial: Optogenetic Tools in the Molecular Spotlight
por: Mathes, Tilo, et al.
Publicado: (2016)

Migraine aura-like symptoms at onset of stroke and stroke-like symptoms in migraine with aura
por: Scutelnic, Adrian, et al.
Publicado: (2022)

Imaging the Premonitory Phase of Migraine
por: Karsan, Nazia, et al.
Publicado: (2020)

Lifestyle Modifications for Migraine Management
por: Agbetou, Mendinatou, et al.
Publicado: (2022)

Auditory Manifestations of Vestibular Migraine
por: Shi, Suming, et al.
Publicado: (2022)

Erratum: Migraine aura-like symptoms at onset of stroke and stroke-like symptoms in migraine with aura
Publicado: (2023)

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study
por: Straburzynski, Marcin, et al.
Publicado: (2023)

Non-invasive Brain Stimulation in Pediatric Migraine: A Perspective From Evidence in Adult Migraine
por: Brighina, Filippo, et al.
Publicado: (2019)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023)

2-Deoxyglucose alleviates migraine-related behaviors by modulating microglial inflammatory factors in experimental model of migraine
por: Qiu, Tao, et al.
Publicado: (2023)

Mechanical Punctate Pain Thresholds in Patients With Migraine Across Different Migraine Phases: A Narrative Review
por: Pan, Li-Ling Hope, et al.
Publicado: (2022)

CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
por: Kamm, Katharina
Publicado: (2022)

Peripheral vascular dysfunction in migraine: a review
por: Sacco, Simona, et al.
Publicado: (2013)

Cognitive Impairment in Children and Adolescents With Migraine
por: Termine, Cristiano, et al.
Publicado: (2018)

The Prevalence of Migraine With Anxiety Among Genders
por: Karimi, Leila, et al.
Publicado: (2020)

Imaging the Visual Network in the Migraine Spectrum
por: Puledda, Francesca, et al.
Publicado: (2019)

Dural Immune Cells, CGRP, and Migraine
por: Balcziak, Louis K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_elncbu83oddt3br64vdkgto289